Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group November 11-12, 2008, Addis Ababa, Ethiopia
|
|
- Cuthbert Haynes
- 6 years ago
- Views:
Transcription
1 The revised TB/HIV indicators and update on the process of harmonization Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group November 11-12, 2008, Addis Ababa, Ethiopia
2 Monitoring and Evaluation Taskforce Update Revision of TB/HIV indicators Data harmonization between partners TB/HIV estimates
3 Revision of TB/HIV indicators Issues: Original M&E guide 2004 Revision of WHO TB and HIV R&R include TB/HIV data PEPFAR and UNGASS have own indicators Indicator harmonisation needed for countries Global Fund wanted to update their M&E toolkit
4 Revision of TB/HIV indicators Recommendations: The task force notes the revision of the TB/HIV indicators currently planned and suggests that these should be in harmony with the current WHO HIV department M&E revisions and should ensure that this revision is able to deliver quality TB /HIV indicator data at national level. Piloting of locality crosschecking of TB and ART registers between programmes should be encouraged as part of the M&E process.
5 Revision of TB/HIV indicators Process to revise Pepfar indicators took place with WHO/HIV&TV DEPT/UNAIDS input. (March/May 08) WHO TB/HIV M&E guide revision meeting 9th to 10th September 2008 synchronised with WHO HIV Department M&E meeting Revision of Generic HIV R&R forms
6 Revision of TB/HIV indicators WHO TB/HIV M&E guide We reduced the number of indicators from 20 to 12 including 2 new ones. % of TB patients screened for HIV during TB treatment Of Tested TB patients % found to be HIV positive % of PLHIV attending testing and counselling and Tx and care who were screened for TB Of those who were screened for TB symptoms, how many were newly diagnosed TB TB patients with HIV status( test result) recorded on TB register/ all TB patients registered HIV positive TB patients / TB patients with HIV test result (status) recorded on register. % in Care (Pre ART /ART registers) who had TB status assessed during their last visit. % in Care (on Pre ART /ART registers) who started TB Tx during last year
7 New indicators: Case detection indicator for TB/HIV Number of TB patients registered with documented HIV status on TB register who are HIV-positive, expressed as a proportion of HIV positive TB patients estimated to occur countrywide each year. Infection control: health workers with TB: Number of health care staff working in facilities providing care for people living with HIV, who develop TB in one year, expressed as a proportion of the total number of health care staff working in facilities providing care for people living with HIV during that same year
8 Case detection indicator Number of HIV positive TB cases 900, , , , ,000 GLOBAL REPORTING of HIV positive TB case detection and provision of CPT and ART , , , ,000-42% 28% 28% 15% 22% 4% 6% 8% 9% 10% 1% 3% 4% Estimated TB HIV 699, , , , ,755 TB HIV detected 28,432 45, , , ,596 CPT provision 9,174 20,541 57, , ,295 ART provision 10,186 9,823 28,864 65,330 70,939 TIME FOR TARGET SETTING- 80% CASE DETECTION? This indicator & target will be dependent on TB programme performance also
9 Revision of TB/HIV indicators Next steps General & web based consultation process: (November to December 2008) Finalise document December 2008 Publish early in 2009
10 Revision of HIV recording and reporting formats to measure TB/HIV indicators AIMS: report on TB status assessment TB treatment provision IPT provision On HIV patient forms On HIV Pre ART & ART Registers On quarterly cross-sectional reporting forms
11 Pre-ART register: TB status follow up
12
13 Revision of HIV recording and reporting formats to measure TB/HIV indicators Next steps Still undergoing consultation and pilot testing Then will need roll out and scale up.
14 The HIV M&E Challenge: Health facility implementation Country Level ART services TB treatment and HIV testing services Three I's must happen all over.
15 Data harmonisation between Recommendation: partners In view of the recent expansion of TB/HIV monitoring and evaluation data sources at global level, there is a need for: Regular international and national review meeting processes to ensure that TB/HIV data collected is comparable and consistent, accurate, comprehensive and based on the country Ministries of Health data source and reporting cycle. Technical/donor partners should support that process.
16 Data harmonization between partners HARMONISATION ACHIEVEMENTS: 1 TB /HIV indicators (Status assessment/ TB tx start while in HIV care/ IPT provision) all firmly embedded in WHO generic HIV patient cards, Pre ART ART registers, and quarterly cross sectional reporting formats to central level. 2 Global Fund revision document has incorporated the revisions suggested by the Monitoring and evaluation guide review committee: 3 Indicators are also in line with the harmonised indicators agreed by Pepfar. i.e WHO PEPFAR & GLOBAL FUND will asking for the same TB/HIV indicator information.
17 Data harmonization between partners HARMONISATION ACHIEVEMENTS: 4 UNAIDS and WHO AIDS department have conducted a reconciliation between their data bases for people on ART starting TB treatment in WHO TB/HIV Global data continues to come in. The 2007 data collected on HIV side (Jan 2007) and by TB side (now) is being compared. 6 TB CAP project approved to look at data collection and harmonisation in 6 countries. (Zambia, Kenya Tanzania, Malawi, Dominican Republic, Cambodia)
18
19 Data harmonisation between partners HIV+TB patients. Pepfar 2 to 5 x NTP to WHO equivalent 1/3 rd of all TB notifications needs further exploration. eg data sources (4 countries)
20 Data Harmonisation Issues How to ensure reconciliation of TB HIV data at country level involving TB & HIV departments and partners. How to roll out the revised HIV recording and reporting formats including the HIV TB indicators.
21 TB/HIV estimates Recommendations: in light of recent individual country reassessment of TB/HIV estimates based on direct country data, there is an urgent need for a dissemination strategy which should include revision of the global IRR and estimates in time for the June 9th global TB HIV leaders forum (New York. This revision should also re-examine the data now available for burden of death estimates, and should include the provision of estimate confidence intervals. ( Not all in agreement: There is a WHO Global Taskforce on TB impact measurement, one of whose subgroups will be reviewing the TB and TB/HIV estimates - meeting first time in June in Den Haag. Interim global estimate revisions between annual reports are not currently planned by WHO STB and would not be sensible)
22 TB/HIV estimates Discussed at Global TB impact measurement task force meeting Recommendations: "3 rd meeting 23 to 25 September 2008" Test out "Kenya analysis" in 2-3 other countries E.g. Tanzania, Malawi, Rwanda Need better sharing of TB and HIV data Need better collection of data needed to estimate TB/HIV burden HIV testing among TB patients TB incidence in those on ART Screening for TB in those with HIV Clearly communicate recommendations to TB/HIV working group
23 Countries testing Tuberculosis Patients for HIV 2007 Proportion of TB patients tested for HIV Key No reported activity < 15% 15% to 40% 40% to 75% More than 75% IS IT TIME FOR TARGET SETTING? - OVER 80% TESTED? The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO All rights reserved
24 Latest data from Global database.. Countries reporting higher TB/HIV We have an additional 8 countries (5 in Africa) reaching the 60% tested threshhold, joining Rwanda Malawi and Kenya) Target?
25 In these 18 countries the HIV prevalence increase in TB patients among tested v estimated is by a factor of 1.8
26 TB/HIV case detection indicator A final thought: the case for higher TB/HIV estimates Table 1. HIV testing and treatment in TB patients, by WHO region, 2007 % of notified TB patients tested for HIV % of tested patients HIVpositive % of estimated HIV-positive TB casesa identified by testing % of identified HIV-positive TB patients started on CPT % of identified HIV-positive TB patients started on ART Regional distribution of estimated HIV-positive TB cases AFR AMR EMR EUR SEAR WPR Global In Africa we are detecting 42% of all estimated TB/HIV cases IN AFRICA around half of TB patients are detected, Only 38 % of these are HIV tested. (i.e. 19% of all estimated TB cases out there) Can it be that amongst these 19% we are detecting 42% of all estimated TB/HIV cases? Or is it more likely to be 19%... less than half?
27 TB/HIV estimates Further exploration and discussions with UNAIDS concerning methodological changes (perhaps incorporating ART eligibility) will be explored by TME/WHO Meanwhile the WHO TB Global Report will continue using direct estimation method if data available/ and revise global IRR in line with best available evidence. We expect TB/HIV estimates to be higher in the next Global Tuberculosis report March 2009
Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities. Avinash Kanchar
Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities Avinash Kanchar Outline WHO guide to M&E of collaborative TB/HIV activities: 2015 Reporting status on Global
More informationControlling TB in the era of HIV
Controlling TB in the era of HIV Christy Hanson, PhD, MPH TB Research Advisor Amy Bloom, MD TB/HIV Advisor TB Incidence rates highest in Africa Estimated new TB cases (all forms) per 100 000 population
More informationC R E A E. Consortium to Respond Effectively to the AIDS-TB Epidemic. An International Research Partnership
C R E A E Consortium to Respond Effectively to the AIDS-TB Epidemic An International Research Partnership Supported by the Bill and Melinda Gates Foundation http://www.tbhiv-create.org Overview What is
More informationThe epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
More informationThe Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific
Health System Strengthening and Sustaining the Response The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific Jintana Ngamvithayapong-Yanai, Ph.D. On behalf of TB/HIV Working Group, the
More informationThe Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific
Health System Strengthening and Sustaining the Response The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific Jintana Ngamvithayapong-Yanai, Ph.D. On behalf of TB/HIV Working Group, the
More informationWHO Rotavirus Vaccine Update Dr. Fatima Serhan WHO/FWC/IVB/EPI
WHO Rotavirus Vaccine Update 2012 Dr. Fatima Serhan WHO/FWC/IVB/EPI WHO estimates that 453 000 child deaths occurred during 2008 due to rotavirus infection 41057 32653 39144 98621 82% of these deaths occurred
More informationIPT IMPLEMENTATION- SWAZILAND EXPERIENCE
IPT IMPLEMENTATION- SWAZILAND EXPERIENCE Gugu Mchunu-National TB/HIV coordinator Programmatic Management of Latent TB infection consultation meeting Seoul, Republic of Korea,27-28 APRIL,2016 TB Epidemiology
More informationTuberculosis: Opportunities and Challenges for Achieving HIV Epidemic Control
Tuberculosis: Opportunities and Challenges for Achieving HIV Epidemic Control Suvanand Sahu Deputy Executive Director Stop TB Partnership Secretariat Tuberculosis TB epidemic is declining very slowly We
More informationInvesting for Impact
Global Fund Strategic Framework: Investing for Impact M&E: Capturing data to improve services Workshop to Scale Up the Implementation of Collaborative TB/HIV Activities in Africa 10-11 April, 2013; Maputo,
More information2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges
Outline of what it will take Tuberculosis Elimination 25: Global and Local Challenges Anne Fanning, MD November 9, 211 21 global TB trends, goals How DOTS happens at country level - an exercise New strategies
More informationTAG-ICW TB/HIV UNGASS Report 2009.
TAG-ICW TB/HIV UNGASS Report 2009. Mechanism to engage the civil society in TB/HIV M&E Francis G. Apina (NETMA+) and J. Syed (TAG) 16 th TB/HIV WG Core Group Meeting Almaty Kazakhstan 26-28 th May 2010.
More informationWorld Health Organization 2013
World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization,
More informationTB surveillance. Philippe Glaziou Dubrovnik, May 2009
TB surveillance Philippe Glaziou Dubrovnik, May 2009 What are the global TB targets? Outcome targets (World Health Assembly, STB Partnership) Case detection ratio > 70% Treatment success > 85% 2015 Impact
More informationWorld Health Organization HIV/TB Facts 2011
World Health Organization HIV/TB Facts 20 Note: The facts and figures of the HIV/TB Facts 20 are drawn from WHO HIV and TB surveillance data from 200 and 2009, as referenced below. Why is tuberculosis
More informationTB/HIV in the WHO European Region Overview, Priorities & Response
TB/HIV in the WHO European Region Overview, Priorities & Response 16 th Core Group Meeting TB/HIV Working Group Stop TB Partnership Almaty, Kazakhstan May 2010 Martin Donoghoe Andrei Dadu, Smiljka de Lussigny
More informationProgress note on the implementation of the recommendations of the 14th TB/HIV Core Group meeting held in Addis Ababa, Ethiopia November 11-12, 2008
Progress note on the implementation of the recommendations of the 14th TB/HIV Core Group meeting held in Addis Ababa, Ethiopia November 11-12, 2008 Recommendations 1. Global and regional response All TB/HIV
More informationTUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION In the WHO Western Pacific Region 2002 Report
TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION 2000 Tuberculosis Control In the WHO Western Pacific Region 2002 Report World Health Organization Office for the Western Pacific Region iii TUBERCULOSIS
More informationCopyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN
UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of
More information511,000 (57% new cases) ~50,000 ~30,000
Latest global TB estimates - 2007 (Updated Mar 2009) All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Estimated number of cases 9.27
More informationThe President s Emergency Plan for AIDS Relief Next Generation Indicators
The President s Emergency Plan for AIDS Relief Next Generation Indicators PEPFAR Next Generation Working in partnership with host nations, PEPFAR will support the following legislative goals: Treatment
More informationImplementing revised TB/HIV recording and reporting tools Country Experience. Dr Nathan Kapata National TB/ Leprosy Programme Manager
Implementing revised TB/HIV recording and reporting tools Country Experience Dr Nathan Kapata National TB/ Leprosy Programme Manager Outline Objective Background Implementation of TB/HIV collaborative
More informationMultidrug-/ rifampicinresistant. (MDR/RR-TB): Update 2017
Multidrug-/ rifampicinresistant TB (MDR/RR-TB): Update 2017 The global TB situation (1) Estimated incidence, 2016 Estimated number of deaths, 2016 All forms of TB HIV-associated TB Multidrug- / rifampicin-resistant
More informationChallenges in Scaling-up TB/HIV collaborative activities in a diverse HIV epidemic -India
Challenges in Scaling-up TB/HIV collaborative activities in a diverse HIV epidemic -India Dr. B. B. Rewari WHO National Consultant National Programme Officer (ART) National AIDS Control Organisation New
More informationTechnology and innovation: Changing dynamics of TB control. Karin Weyer
Technology and innovation: Changing dynamics of TB control Karin Weyer Latest news 1. New tools finally a reality 2. Universal access for all affected from TB 3. Emphasis on early case detection and treatment
More informationIPT BOTSWANA EXPERIENCE
IPT BOTSWANA EXPERIENCE Oaitse I Motsamai RN, MW, B Ed, MPH Ministry of Health Botswana 11 th November 2008 Addis Ababa, Ethiopia OUTLINE Botswana context Rationale for IPT in Botswana Pilot Current Programme
More informationChallenges and solutions in making evidence-based national vaccination policies and recommendations
Challenges and solutions in making evidence-based national vaccination policies and recommendations Philippe Duclos, WHO 15th ADVAC, Les Pensières, Veyrier du Lac, May 19, 2014 Developing evidence-based
More informationWhat can be done against XDR-TB?
What can be done against XDR-TB? Dr Matteo Zignol Stop TB Dep. World Health Organization Geneva 16 th Swiss Symposium on tuberculosis Münchenwiler, 22 March 2007 XDR-TB Extensive Drug Resistance XDR =
More informationEstimates of TB incidence, prevalence and mortality. Philippe Glaziou Cairo, October 2009
Estimates of TB incidence, prevalence and mortality Philippe Glaziou Cairo, October 2009 Outline Main sources of information Incidence From incidence to prevalence From incidence to mortality TB/HIV MDR-TB
More informationMonitoring top 10 indicators. Philippe Glaziou September 2016
Monitoring top 10 indicators Philippe Glaziou September 2016 Global TB Report 2016 outline top-10 indicators 1. Introduction 2. The SDGs, End TB Strategy and a new era of global TB monitoring 3. TB disease
More informationTB Situation in Zambia/ TB Infection Control Program. Dr N Kapata Zambia National TB/Leprosy Control Programme Manager
/ TB Infection Control Program Dr N Kapata Zambia National TB/Leprosy Control Programme Manager Background Major public health problem Current (2014) notification rate is at 286/ 100,000 population. The
More informationTB epidemic and progress towards the Millennium Development Goals
Open Forum 4: Key issues in TB Drug Development, August 18, 2010, Addis Ababa, Ethiopia TB epidemic and progress towards the Millennium Development Goals Haileyesus Getahun Stop TB Department, WHO Geneva,
More informationRegional Response Plan for TB-HIV
Regional Response Plan for TB-HIV 2017 2021 SEA-TB-370 Regional Response Plan for TB-HIV 2017 2021 Regional Response Plan for TB-HIV 2017 2021. World Health Organization 2017 Some rights reserved. This
More informationMethodological issues in the use of anthropometry for evaluation of nutritional status
Methodological issues in the use of anthropometry for evaluation of nutritional status Monika Blössner WHO Department of Nutrition for Health and Development Methodological issues in the use of anthropometry?
More informationTuberculosis Screening and IPT: Experience from India
Tuberculosis Screening and IPT: Experience from India Dr B.B.Rewari WHO National consultant Care, Support and Treatment National Programme Officer (ART) National AIDS Control Organization New Delhi-110001,
More informationScaling up collaborative TB/HIV activities: achievements, challenges, and opportunities in Viet Nam
Scaling up collaborative TB/HIV activities: achievements, challenges, and opportunities in Viet Nam 20 th International AIDS Conference, 20 July 2014, Melbourne, Australia Nguyen Hoang Long, MD, Ph.D.
More informationCOMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE
COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE Exposing a hidden epidemic Kenya TB/HIV TEAM Introduction Population: 40 million 15 th among the 22 high TB burden countries 2012: TB case notification
More informationXDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever
More informationIntercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net
WHO-EM/MAL/367/E Summary report on the Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net Muscat, Oman 22 24 September 2011 World Health Organization 2012
More informationIPT Policy Review South Africa. WHO TB/HIV Working Group meeting
IPT Policy Review South Africa WHO TB/HIV Working Group meeting Outline Background Policy Environment Policy and Guidelines TB/HIV Collaboration Policy development process BACKGROUND Population: 53 Million
More informationChange In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi:
Change In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi: 1986-2009 Rein Houben/Sebastian Mboma Karonga Prevention Study Incidence of SS+ TB (n/100,000/year
More informationSession-1: Template for country presentation (EXISTING Indicators)
Session-1: Template for country presentation (EXISTING Indicators) Instruction This presentation is expected to provide Country perspective on use of following Existing indicators among the top 10 indicators
More information2. Treatment coverage: 3. Quality of care: 1. Access to diagnostic services:
The theme for World TB Day 2014 is Reach the missed 3 million. Every year 3 million people who fall ill with TB are missed by health systems and do not always get the TB services that they need and deserve.
More informationMay 26-28, 2010, Almaty, Kazakhstan November 2011
Progress note of the recommendations of the 16 th TB/HIV Core Group Meeting Report May 26-28, 2010, Almaty, Kazakhstan November 2011 1. Structural and organizational barriers The Core Group urges Ministries
More informationKey Strategic Decisions Common Options Country Examples
REACHING THE THIRD 90: IMPLEMENTING HIGH QUALITY VIRAL LOAD MONITORING AT SCALE Key Strategic Decisions for Countries Designing & Scaling-Up Viral Load Services 1. 2. 3. 4. 5. How will leadership and/or
More informationComments on this bulletin are welcome. Please to Dr. Mary Agócs
Global Invasive Bacterial Vaccine Preventable Diseases (IB-VPD) Information and Surveillance Bulletin Reporting Period: January through December 2010 Volume 4: October 2011 The World Health Organization
More informationDr. Natella Rakhmanina Senior Technical Advisor, Elizabeth Glaser Pediatric AIDS Foundation October 2018
Dr. Natella Rakhmanina Senior Technical Advisor, Elizabeth Glaser Pediatric AIDS Foundation October 2018 1 Number of young people living with HIV (aged 15 19 years) by mode of HIV acquisition, 25 countries,*
More informationScaling up priority HIV/AIDS interventions in the health sector
TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June
More information1.0 BACKGROUND / PROJECT DESCRIPTION
TERMS OF REFERENCE (TOR) FOR A CONSULTANT TO PREPARE AND ORGANIZE A NATIONAL ACTION PLAN MEETING UNDER THE AFRICAN REGIONAL HIV GRANT REMOVING LEGAL BARRIERS. General Information Intervention: Work Description:
More informationThe New WHO guidelines on intensified TB case finding and Isoniazid preventive therapy and operational considerations
Workshop to accelerate the implementation of the Three Is for HIV/TB and earlier initiation of ART in Southern Africa, March 14-18, 2011, Johannesburg, South Africa. The New WHO guidelines on intensified
More informationTUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.
30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE
More informationIntegration of TB and HIV services: Swaziland s experience. Dr Hloniphile Mabuza ART/TB Clinical Advisor SNAP/URC
Integration of TB and HIV services: Swaziland s experience Dr Hloniphile Mabuza ART/TB Clinical Advisor SNAP/URC Map 1: Map of southern Africa showing location of Swaziland Country overview Surface area:17400
More informationThe WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps
The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps Matteo Zignol STOP TB Department World Health Organization TB surveillance and
More informationDECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION
DECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION AFRO Library Cataloguing-in-Publication Data Declaration on Acceleration of HIV Prevention efforts in the African Region 1. Acquired
More informationHealth Situation Room. Introduction to the Concept 2018
Health Situation Room Introduction to the Concept 2018 What is a Health Situation Room? Health Situation Room is an innovative data visualization platform, which allows decision makers and programme
More informationThe State of Measles and Rubella in the WHO European Region
The State of Measles and Rubella in the WHO European Region Mark Muscat Vaccine-preventable Diseases and Immunization Rome, Italy, 16-17 June 2016 All six WHO Regions have measles elimination goals 2 Annual
More informationTB Control activities and Success factors and Challenges for monitoring and Evaluation of the Mangement of LTBI in Cambodia
TB Control activities and Success factors and Challenges for monitoring and Evaluation of the Mangement of LTBI in Cambodia Global Consultation on Programmatic Management of LTBI 27-28 /04/ 2016 Seoul,
More informationRevitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment
17 th TB/HIV Core Group meeting, Beijing, China. November 11, 2011 Revitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment Haileyesus Getahun Stop TB Department WHO Outline
More informationThe Three I s for HIV/TB and Rolling out IPT beyond Pilot -India
The Three I s for HIV/TB and Rolling out IPT beyond Pilot -India Dr. B. B. Rewari WHO National Consultant National Programme Officer (ART) National AIDS Control Organisation New Delhi, India 1 Content
More informationAnnex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)
IMPACT INDICATORS (INDICATORS PER GOAL) HIV/AIDS TUBERCULOSIS MALARIA Reduced HIV prevalence among sexually active population Reduced HIV prevalence in specific groups (sex workers, clients of sex workers,
More informationUGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
MINISTRY OF HEALTH UGANDA TIOL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME Revised Strategic Plan 2015/16-2019/20 Monitoring and Evaluation Plan Narrative of the Operational, Budget and Technical Assistance
More informationDelivering Integrated HIV/TB Services in India: Challenges and Opportunities in National AIDS Control Program (NACP) IV.
Delivering Integrated HIV/TB Services in India: Challenges and Opportunities in National AIDS Control Program (NACP) IV. Introduction: Deshmukh Rajesh 1 Ashok Kumar 1 K.S.Sachdeva 2 Amar Shah 2 India is
More informationUNGASS COUNTRY PROGRESS REPORT Republic of Armenia
UNGASS COUNTRY PROGRESS REPORT Republic of Armenia Reporting period: January 2006 December 2007 I. Status at a glance The Armenia UNGASS Country Progress Report was developed under the overall guidance
More informationPROGRESS ON IMPLEMENTATION OF THE 3Is IN SOUTH AFRICA. Yogan Pillay Deputy Director General Strategic Health Programmes South Africa
PROGRESS ON IMPLEMENTATION OF THE 3Is IN SOUTH AFRICA Yogan Pillay Deputy Director General Strategic Health Programmes South Africa South Africa Population: 49 320 500 Mil Province Population 2009 mid
More informationEnd TB Strategy top 10 indicators: current status in participant countries
End TB Strategy top 10 indicators: current status in participant countries Dennis FALZON Global TB Programme, WHO/HQ Geneva Regional WHO / Global Fund meeting Kenya 20 September 2016 Objectives of the
More informationMAPS ON GLOBAL TOBACCO CONTROL POLICY DATA
APPENDIX XII: MAPS ON GLOBAL TOBACCO CONTROL POLICY DATA Appendix XII provides global overview maps on monitoring tobacco prevalence, smoke-free environments, treatment of tobacco dependence, health warnings
More informationSuccesses and remaining barriers to routine TB screening and implementation of IPT in Cambodia
Successes and remaining barriers to routine TB screening and implementation of IPT in Cambodia Mean Chhi Vun, MD, MPH NCHADS Director mchhivun@nchads.org Scaling up the implementation of the TB/HIV collaborative
More informationON THE ROAD TO ENDING TB HIGHLIGHTS FROM THE 30 HIGHEST TB BURDEN COUNTRIES
ON THE ROAD TO ENDING TB HIGHLIGHTS FROM THE 30 HIGHEST TB BURDEN COUNTRIES VISION: A WORLD FREE OF TB Zero deaths, disease and suffering due to tuberculosis GOAL: END THE GLOBAL TB EPIDEMIC INDICATORS
More informationTUBERCULOSIS CONTROL WHO WESTERN PACIFIC REGION
TUBERCULOSIS CONTROL in WHO WESTERN PACIFIC REGION 2000 Report (Cases Notified in 1999) WORLD HEALTH ORGANIZATION Western Pacific Regional Office TUBERCULOSIS CONTROL IN WHO WESTERN PACIFIC REGION (Cases
More informationThe Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control
The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control GAVI Partners Forum 4 6 December 2012, Dar es Salaam, Tanzania Maya van den Ent, MPH, UNICEF Peter Strebel,
More informationGLOBAL TB IMPACT MEASUREMENT
GLOBAL TB IMPACT MEASUREMENT What is it? Why is it important? How can it be done? What will it cost? 1. What is global TB impact measurement and why is it important? Global TB Impact Measurement is the
More informationACHAP LESSONS LEARNED IN BOTSWANA KEY INITIATIVES
ACHAP Together with our company s foundation, a U.S.-based, private foundation, and the Bill & Melinda Gates Foundation, we established the African Comprehensive HIV/AIDS Partnerships (ACHAP) in 2000 to
More informationName of the presenter
Progress in tuberculosis care: setting the scene for Central Asia Name of the presenter Gombogaram Tsogt, Shalva Gamtsemlidze Quality Health Care Project Global TB estimates All forms of TB greatest number
More informationHIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS
POLICY BRIEF HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS CONSOLIDATED GUIDELINES JULY 2014 Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for
More informationChildhood TB and new TB drugs in the WHO European Region
Andrei Dadu Carl Cordonnier Maxim Dondiuk Childhood TB and new TB drugs in the WHO European Region Kigali, Rwanda, 09/10/ 2017 Dr Martin van den Boom, MD, MSc PH, WHO Regional Office for Europe, Joint
More informationTime to implement: WHO guidelines on TB Preventive Treatment
Time to implement: WHO guidelines on TB Preventive Treatment WHO End TB Strategy TARGETS: 90% reduction of deaths and 80% reduction in incidence by 2030 Early diagnosis Integrated, of TB including universal
More informationA Call to Action Children The missing face of AIDS
A Call to Action Children The missing face of AIDS Scaling up Paediatric HIV Care Treatment in resource limited settings Dr Chewe Luo MMed(Paed); MTropPaed; PhD UNICEF Health Section Programme Division
More informationTB Disease Prevalence Survey - Overview and Introduction of the TF
TB Disease Prevalence Survey - Overview and Introduction of the TF Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int
More informationWHO Global Task Force on TB Impact Measurement An overview
WHO Global Task Force on TB Impact Measurement An overview Katherine Floyd (WHO/GTB/TME) 3 rd meeting of the TB estimates subgroup Glion-sur-Montreux, 31March 2 April 2015 GLOBAL TB PROGRAMME 1. Broad
More informationCall to Action To Accelerate Access to DR-TB Drugs: 2016 Update
Call to Action To Accelerate Access to DR-TB Drugs: 2016 Update June 3, 2016 On March 10 th, 2015, Médecins Sans Frontières (MSF), ACTION Global Health Advocacy Partnership, SWIFT Response Project, Treatment
More informationTB Disease Prevalence Survey - Progress Report
TB Disease Prevalence Survey - Progress Report 30 Oct 2011, Lille Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int
More informationOkinawa, Toyako, and Beyond: Progress on Health and Development
Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,
More informationThe Regional Centre of Excellence (CoE) on Programmatic Management of Drug Resistant Tuberculosis (PMDT)
The Regional Centre of Excellence (CoE) on Programmatic Management of Drug Resistant Tuberculosis (PMDT) General Information The Centre of Excellence (CoE) on Programmatic Management of Drug Resistant
More informationMeasuring TB burden and access to TB services for people who inject drugs in the WHO European Region, 2010 and 2011
Measuring TB burden and access to TB services for people who inject drugs in the WHO European Region, 2010 and 2011 Annabel Baddeley Global TB Programme WHO, Geneva Outline of presentation Global and European
More informationMeasles and Rubella Global Update SAGE 19 October 2017
Measles and Rubella Global Update SAGE 19 October 2017 Alya Dabbagh WHO HQ, IVB/EPI Global update Overview Regional progress and challenges M&RI Midterm Review updates Economics of measles and rubella
More informationA guide to monitoring and evaluation for collaborative TB/HIV activities
A guide to monitoring and evaluation for collaborative TB/HIV activities A guide to monitoring and evaluation for collaborative TB/HIV activities Stop TB Department and Department of HIV/AIDS, World Health
More informationGlobal Polio Eradication & Endgame Strategy. December 2015
Global Polio Eradication & Endgame Strategy December 2015 Poliovirus detection & interruption OPV withdrawal, IPV introduction, RI strengthening Containment & Global Certification Legacy Planning Polio
More informationTB/HIV Monitoring & Advocacy Project Interview Tool
TB/HIV Monitoring & Advocacy Project Interview Tool This interview tool is based upon the Interim Policy on Collaborative TB/HIV Activities of the World Health Organization. 1 It is designed to help you
More informationAccelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges
Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges George Siberry, MD, MPH OGAC Senior Technical Advisor for Pediatrics March, 2016 Compared to Adults, Children (
More informationJOINT TB AND HIV PROGRAMMING
JOINT TB AND HIV PROGRAMMING Haileyesus Getahun, WHO. On behalf of the Global Fund Interagency TB and HIV Working Group (Global Fund, PEPFAR, Stop TB Partnership, UNAIDS, WHO) I was admitted in a hospital
More informationPEPFAR and Treatment 2.0
PEPFAR and Treatment 2.0 World Health Assembly Treatment 2.0 Side Meeting May 19, 2011 Charles Holmes, MD, MPH Office of the US Global AIDS Coordinator President s Emergency Plan for AIDS Relief Drug Optimization
More informationTable 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,
Volume 7 Issue 5 May 2013 ISSN 1814 3601 Table 1. case classification and by country and area, WHO Western Pacific Region, 2008 2013 1 confirmed 2 2 009 per confirmed 2 2 010 2 011 2 012 2013 1 Confirmed
More informationThe ENRICH Study Evaluating an Innovative Approach to Increasing Use of Isoniazid Preventive Therapy to Prevent TB among People Living with HIV
The ENRICH Study Evaluating an Innovative Approach to Increasing Use of Isoniazid Preventive Therapy to Prevent TB among People Living with HIV Background and Rationale People living with HIV have a greatly
More informationLOGFRAME FOR LESOTHO
LOGFRAME FOR LESOTHO Linking HIV Sexual Reproductive Health Rights in Southern Africa (2011-2014) Outcome: Lesotho has addressed barriers to efficient effective linkages between HIV SRHR policies services
More informationAfrican Health Development & Financing Parliamentary Policy & Budget Action Plan
AfricanHealthDevelopment&Financing ParliamentaryPolicy&BudgetActionPlan AdoptedBytheNetworkofAfricanParliamentariansforHealthDevelopment&Financing 1 UNECAConferenceCentre.September9,2009.AddisAbaba,Ethiopia
More informationDrug and Health Care Delivery: A perspective from Cambodia and Ethiopia
Drug and Health Care Delivery: A perspective from Cambodia and Ethiopia Sok Thim and Anne Goldfeld Cambodian Health Committee/ Global Health Committee Immune Disease Institute Harvard Medical School November
More informationA smart and doable investment
90-90-90 A smart and doable investment As of December 2013 Adults and children living with HIV Adults and children newly infected Adult & child deaths due to AIDS 35.0 million [33.2 million 37.2 million]
More informationLatent tuberculosis infection
Latent tuberculosis infection Updated and consolidated guidelines for programmatic management ANNEX 2 Evidence-to-Decision and GRADE tables Latent tuberculosis infection Updated and consolidated guidelines
More informationSituation of the HIV Epidemic in Cambodia
Scaling up Collaborative TB/HIV Activities: Challenges, Achievements and Opportunities for Eliminating TB Related-Deaths among PLHIV in Cambodia, by 2020 High Level International Consultation of the WHO
More informationTB Disease Prevalence Survey - Overview, why and how
TB Disease Prevalence Survey - Overview, why and how Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int 3 strategic
More information